Inogen Announces Participation in Upcoming Investor Conferences

Download as PDF

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that the Company’s management will be participating in two upcoming investor conferences.

Inogen’s CEO, Ray Huggenberger, and CFO, Alison Bauerlein, are scheduled to present at the 2016 Leerink Global Healthcare Conference in New York City on Wednesday, February 10, at 1:25pm ET. Interested parties can access the live audio webcast of this event from the Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen management is also scheduled to participate in the BTIG Third Annual Snowbird Medical Technology, Diagnostics, and Healthcare IT Conference in Snowbird, Utah on Wednesday, February 24. Due to the one-on-one only format of the event, no webcast will be available.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. For more information, please visit www.inogen.com.

Inogen, Inc.
Investor Relations:
ir@inogen.net
805-562-0500 ext 7
or
Media:
Byron Myers
805-562-0503

Source: Inogen, Inc.

Released January 27, 2016